Complementary Peptide Therapies in the GLP-1 Era As GLP-1 therapies (both injectable and oral) become the pharmacological foundation of metabolic disease management, complementary peptide therapies address aspects of health that GLP-1 alone doesn't fully cover
Key Takeaways GLP-1 support supplements target the predictable consequences of drug-driven appetite suppression: lean-mass loss, sub-DRI protein, fiber, and micronutrient intake, and GI side effects
Persistent bruising suggests either a technique issue (angle, depth, or pressure) or an underlying condition affecting blood vessels or clotting
While some people report improvements in overall hair health, these changes often occur over months rather than days or weeks
In aged mouse models, researchers observed that FOXO4-DRI administration was associated with changes in senescence biomarker levels and functional parameters